Sera Prognostics Inc Sustainability Reports
Sera Prognostics, Inc. is a women's health diagnostics company that develops and commercializes blood-based biomarker tests and predictive analytics. Its flagship product, the PreTRM test, evaluates the individualized risk of spontaneous premature birth to enable early medical interventions.
Sector: Healthcare & social services
Country: United States
Exchange: Nasdaq
FIGI: BBG001V0FR24
3 reports from 2021 to 2023